Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Risa Takayanagi

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 8, 2011
[Development and evaluation of effective learning system for patient interview training as a part of pre-education clinical pharmacy practice]Haruko Yokoyama, Risa Takayanagi, Yasuhiko Yamada
Biological & Pharmaceutical Bulletin|June 2, 2017
Analysis of Clinical Efficacy and Adverse Effects of β-Blocking Agents Used Clinically for Chronic Heart FailureRisa Takayanagi, Kaori Fujito, Koji Kimura, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 2, 2017
Study of Safety Evaluation in Dispensing of Medicines-Analysis of Relationship between Dispensing Error Rate, Inspecting Error Rate, and Malpractice RateShinji Soeda, Risa Takayanagi, Masayuki Watanabe, et al.
Rheumatology International|January 10, 2013
Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancyKanae Tani, Risa Takayanagi, Haruko Yokoyama, et al.
Biopharmaceutics & Drug Disposition|May 24, 2018
Pharmacokinetic and pharmacodynamic model for analysis of adalimumab administered for Crohn's diseaseKoji Kimura, Atsushi Yoshida, Risa Takayanagi, et al.
Medical Oncology (Northwood, London, England)|September 10, 2017
Theoretical method for evaluation of therapeutic effects and adverse effects of epidermal growth factor receptor tyrosine kinase inhibitors in clinical treatmentKoji Kimura, Risa Takayanagi, Tomoki Fukushima, et al.
Drug Metabolism and Pharmacokinetics|January 15, 2014
Theory-based analysis of the anti-inflammatory effect of TNF inhibitors on rheumatoid arthritisKoji Kimura, Risa Takayanagi, Haruko Yokoyama, et al.
Rheumatology International|August 4, 2010
Theory-based analysis of anti-inflammatory effect of infliximab on Crohn's disease and rheumatoid arthritisKoji Kimura, Risa Takayanagi, Haruko Yokoyama, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 17, 2016
Effects of tumor necrosis factor α-857C/T polymorphism on the expression of tumor necrosis factor αKoji Kimura, Risa Takayanagi, Haruko Yokoyama, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 28, 2013
Interactions between new quinolone antibacterials and diagnostic drug containing manganeseMoeko Hosono, Haruko Yokoyama, Risa Takayanagi, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 8, 2011
[Development and evaluation of effective learning system for patient interview training as a part of pre-education clinical pharmacy practice]Haruko Yokoyama, Risa Takayanagi, Yasuhiko Yamada
Biological & Pharmaceutical Bulletin|June 2, 2017
Analysis of Clinical Efficacy and Adverse Effects of β-Blocking Agents Used Clinically for Chronic Heart FailureRisa Takayanagi, Kaori Fujito, Koji Kimura, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 2, 2017
Study of Safety Evaluation in Dispensing of Medicines-Analysis of Relationship between Dispensing Error Rate, Inspecting Error Rate, and Malpractice RateShinji Soeda, Risa Takayanagi, Masayuki Watanabe, et al.
Rheumatology International|January 10, 2013
Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancyKanae Tani, Risa Takayanagi, Haruko Yokoyama, et al.
Biopharmaceutics & Drug Disposition|May 24, 2018
Pharmacokinetic and pharmacodynamic model for analysis of adalimumab administered for Crohn's diseaseKoji Kimura, Atsushi Yoshida, Risa Takayanagi, et al.
Medical Oncology (Northwood, London, England)|September 10, 2017
Theoretical method for evaluation of therapeutic effects and adverse effects of epidermal growth factor receptor tyrosine kinase inhibitors in clinical treatmentKoji Kimura, Risa Takayanagi, Tomoki Fukushima, et al.
Drug Metabolism and Pharmacokinetics|January 15, 2014
Theory-based analysis of the anti-inflammatory effect of TNF inhibitors on rheumatoid arthritisKoji Kimura, Risa Takayanagi, Haruko Yokoyama, et al.
Rheumatology International|August 4, 2010
Theory-based analysis of anti-inflammatory effect of infliximab on Crohn's disease and rheumatoid arthritisKoji Kimura, Risa Takayanagi, Haruko Yokoyama, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 17, 2016
Effects of tumor necrosis factor α-857C/T polymorphism on the expression of tumor necrosis factor αKoji Kimura, Risa Takayanagi, Haruko Yokoyama, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 28, 2013
Interactions between new quinolone antibacterials and diagnostic drug containing manganeseMoeko Hosono, Haruko Yokoyama, Risa Takayanagi, et al.
Pageof 5